High-Deductible Health Policies Linked To Delayed Diagnosis And Treatment

In 2017, Susan learned that she carries a genetic mutation that may elevate her lifetime risk of developing breast cancer to 69 percent. Her doctor explained that individuals who have this mutation in the BRCA2 gene have choices in treatment. Some people opt for a preventive double mastectomy. But Susan could instead choose to undergo increased cancer screenings, which, for her, would mean an annual mammogram and annual MRI scan.